Wall Street analysts expect Cavium Inc (NASDAQ:CAVM) to post $259.99 million in sales for the current fiscal quarter, according to Zacks. Six analysts have made estimates for Cavium’s earnings. The highest sales estimate is $265.00 million and the lowest is $255.00 million. Cavium posted sales of $229.58 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 13.2%. The business is expected to report its next quarterly earnings results on Wednesday, April 25th.
According to Zacks, analysts expect that Cavium will report full year sales of $259.99 million for the current financial year, with estimates ranging from $1.09 billion to $1.13 billion. For the next year, analysts anticipate that the company will post sales of $1.26 billion per share, with estimates ranging from $1.22 billion to $1.30 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research analysts that that provide coverage for Cavium.
Cavium (NASDAQ:CAVM) last posted its quarterly earnings results on Wednesday, January 31st. The semiconductor provider reported $0.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.81 by $0.02. Cavium had a positive return on equity of 14.07% and a negative net margin of 7.00%. The firm had revenue of $260.36 million during the quarter, compared to analyst estimates of $260.05 million. During the same quarter in the previous year, the firm earned $0.56 EPS. Cavium’s quarterly revenue was up 15.1% compared to the same quarter last year.
Several equities research analysts recently commented on CAVM shares. KeyCorp reiterated a “positive” rating and issued a $90.00 price objective (up from $80.00) on shares of Cavium in a report on Thursday, November 16th. They noted that the move was a valuation call. Benchmark downgraded Cavium from a “buy” rating to a “hold” rating in a report on Monday, November 20th. Jefferies Group downgraded Cavium from a “buy” rating to a “hold” rating in a report on Tuesday, November 21st. Loop Capital downgraded Cavium from a “buy” rating to a “hold” rating and set a $84.00 price objective for the company. in a report on Tuesday, November 21st. Finally, Morgan Stanley downgraded Cavium from an “overweight” rating to an “equal weight” rating and set a $77.00 price objective for the company. in a report on Tuesday, November 21st. Eleven analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $79.93.
In other Cavium news, SVP Vincent P. Pangrazio sold 8,000 shares of the business’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $87.19, for a total transaction of $697,520.00. Following the completion of the sale, the senior vice president now directly owns 54,577 shares in the company, valued at approximately $4,758,568.63. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Vincent P. Pangrazio sold 20,777 shares of the business’s stock in a transaction dated Thursday, March 8th. The shares were sold at an average price of $90.08, for a total value of $1,871,592.16. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 320,538 shares of company stock valued at $28,285,211. Corporate insiders own 4.65% of the company’s stock.
Several hedge funds have recently bought and sold shares of the company. Aperio Group LLC lifted its position in shares of Cavium by 8.2% during the 3rd quarter. Aperio Group LLC now owns 10,397 shares of the semiconductor provider’s stock valued at $686,000 after buying an additional 792 shares in the last quarter. TD Asset Management Inc. lifted its position in shares of Cavium by 4.6% during the 3rd quarter. TD Asset Management Inc. now owns 18,200 shares of the semiconductor provider’s stock valued at $1,200,000 after buying an additional 800 shares in the last quarter. Amalgamated Bank lifted its position in shares of Cavium by 7.6% during the 4th quarter. Amalgamated Bank now owns 13,413 shares of the semiconductor provider’s stock valued at $1,124,000 after buying an additional 945 shares in the last quarter. State Board of Administration of Florida Retirement System lifted its position in shares of Cavium by 1.1% during the 3rd quarter. State Board of Administration of Florida Retirement System now owns 98,098 shares of the semiconductor provider’s stock valued at $6,469,000 after buying an additional 1,030 shares in the last quarter. Finally, Keybank National Association OH lifted its position in shares of Cavium by 12.6% during the 3rd quarter. Keybank National Association OH now owns 9,244 shares of the semiconductor provider’s stock valued at $610,000 after buying an additional 1,034 shares in the last quarter. 92.03% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Cavium (NASDAQ:CAVM) opened at $90.99 on Friday. Cavium has a twelve month low of $56.96 and a twelve month high of $92.66. The company has a market capitalization of $6,355.56, a PE ratio of -89.21, a P/E/G ratio of 2.37 and a beta of 1.28. The company has a debt-to-equity ratio of 0.78, a current ratio of 2.80 and a quick ratio of 2.27.
Cavium, Inc is a provider of integrated semiconductor processors that enable intelligent processing for wired and wireless infrastructure and cloud for networking, communications, storage and security applications. The Company’s products consist of multi-core processors for embedded and data center applications, network connectivity for server and switches, storage connectivity, and security processors for offload and appliance.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cavium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cavium and related companies with MarketBeat.com's FREE daily email newsletter.